Long-term outcomes of allogeneic stem cell transplant in multiple myeloma

Long-term outcomes of allogeneic stem cell transplant in multiple myeloma

Abstract Allogeneic stem cell transplant (allo SCT) for multiple myeloma (MM) is potentially curative in some, while toxic in many others. We retrospectively analyzed 85 patients diagnosed with MM who underwent allo SCT as frontline or salvage therapy between 2000 and 2022 at Mayo Clinic Rochester a...

Full description

Bibliographic Details
Main Authors: Walker M. Schmidt, Nirosha D. Perera, Francis K. Buadi, Suzanne R. Hayman, Shaji K. Kumar, Angela Dispenzieri, David Dingli, Joselle Cook, Martha Q. Lacy, Prashant Kapoor, Nelson Leung, Eli Muchtar, Rahma M. Warsame, Taxiarchis Kourelis, Moritz Binder, Wilson I. Gonsalves, William J. Hogan, Morie A. Gertz
Format: Article
Language:English
Published: Nature Publishing Group 2023-08-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-023-00900-z

Internet

https://doi.org/10.1038/s41408-023-00900-z

Similar Items